22 results
424B3
SLNO
Soleno Therapeutics Inc
24 Jul 17
Prospectus supplement
12:00am
or Buyer’s respective trade secrets and other confidential or proprietary information, including customer lists, supplier lists, marketing and business … foreign, state or local law.
“Customer Data” means any and all information (a) collected by the Company about visitors to or users of their respective
424B3
SLNO
Soleno Therapeutics Inc
14 Oct 15
Prospectus supplement
12:00am
programs (in both source code and object code form), technology, processes, designs and specifications, technical data and customer lists, tangible … of the Purchaser and its Affiliates) and discounts, rebates, chargebacks, customer returns and allowances given or taken, as appropriate, related
424B3
SLNO
Soleno Therapeutics Inc
14 Oct 15
Prospectus supplement
12:00am
(in both source code and object code form), technology, processes, designs and specifications, technical data and customer lists, tangible or intangible … of the Purchaser and its Affiliates) and discounts, rebates, chargebacks, customer returns and allowances given or taken, as appropriate, related to such sales
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
of the Company, on the one hand, and any director, officer, shareholder, customer or supplier of the Company or any affiliate of the Company, on the other hand … ; rights of publicity; copyrights, works of authorship, software, data, databases, systems, and technology; licenses, formulae, customer lists, know
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
or indirect, exists between or among any of the Company or any affiliate of the Company, on the one hand, and any director, officer, shareholder, customer … , databases, systems, and technology; licenses, formulae, customer lists, know-how, trade secrets and other unpatented and/or unpatentable proprietary
8-K
EX-1.1
hugnieubef9s
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
8-K
EX-1.1
kit0pisn2aybyehhvdi3
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
424B3
qu6ac1p6ll2g
14 Oct 15
Prospectus supplement
12:00am
10-K
g9cbqfr9l2nf2crft
13 Mar 15
Annual report
12:00am